Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ikchan Song, Jimyung Kim, Kyechul Kwon, Sunhoe Koo & Dukyeon Jo. (2016) Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura. Hematology 21:3, pages 187-192.
Read now
Read now
Articles from other publishers (21)
Omar Ahmed Abdelwahab, Ahmed Mechi, Shereen Gahlan, Fatima-Elzahraa Hamadein, Hallas Kadhim, Doaa Ismail, Youssef Soliman & Mohamed El‑Samahy. (2023) Efficacy and safety of mycophenolate mofetil in patients with immune thrombocytopenic purpura: a systematic review and meta-analysis. Clinical Rheumatology.
Crossref
Crossref
Alexandra Schifferli, Axel Rüfer, Alicia Rovo, Falk Nimmerjahn, Nathan Cantoni, Andreas Holbro, Geneviève Favre, Jan Dirks, Anna Wieland, Heike Faeth, Renata Pereira & Thomas Kühne. (2023)
Immunomodulation with romiplostim as a second‐line strategy in primary immune thrombocytopenia: The
iROM
study
. British Journal of Haematology 203:1, pages 119-130.
Crossref
Crossref
Julia-Annabell Georgi, Jan Moritz Middeke, Martin Bornhäuser, Axel Matzdorff & Karolin Trautmann-Grill. (2023) Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP. Blood Advances 7:14, pages 3710-3724.
Crossref
Crossref
Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi & Nupur NagarKrishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi & Nupur Nagar. 2023. Protein-Protein Interactions. Protein-Protein Interactions
343
428
.
Hend Nabil Ellithy, Sherif Mohamed Yousry, Asmaa Abdel-Aal, Lelian Tawadros & Nouran Momen. (2022) Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population. Blood Research 57:3, pages 229-234.
Crossref
Crossref
Chewei Ou, Hung Chang, Yu-Shin Hung, Ming-Chung Kuo, Pei-Ling Li & Tung-Liang Lin. (2022) Changing profile of platelet activity and turnover indices during treatment response of immune thrombocytopenia. Clinical and Experimental Medicine 22:4, pages 595-603.
Crossref
Crossref
Yao Wang, Xi Jia, Ling Zhou, Jie Yin, Yunxiao Zhao, Lan Dai, Bin Zuo & Yang He. (2021) Increased let-7b-5p is associated with enhanced BAFF-R expression and B cell survival in immune thrombocytopenia. International Immunopharmacology 93, pages 107393.
Crossref
Crossref
Tong Zhang, Jianxuan Sun, Jiali Cheng, Wei Yin, Jingwen Li, Heather Miller, Andrés A Herrada, Heng Gu, Hongmei Song, Yan Chen, Quan Gong & Chaohong Liu. (2021) The role of ubiquitinase in B cell development and function. Journal of Leukocyte Biology 109:2, pages 395-405.
Crossref
Crossref
Haiying Lu, Qiaodan Zhou, Jun He, Zhongliang Jiang, Cheng Peng, Rongsheng Tong & Jianyou Shi. (2020) Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Meysam Moghbeli. (2019) Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview. Cellular and Molecular Neurobiology 40:1, pages 65-85.
Crossref
Crossref
Masumeh Maleki Behzad, Ali Amin Asnafi, Kaveh Jaseb, Mohammad Ali Jalali Far & Najmaldin Saki. (2017) Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches. APMIS 125:12, pages 1042-1055.
Crossref
Crossref
Mingen Lyu, Yating Hao, Yang Li, Cuicui Lyu, Wenjie Liu, Huiyuan Li, Feng Xue, Xiaofan Liu & Renchi Yang. (2017)
Upregulation of CD72 expression on CD19
+
CD27
+
memory B cells by CD40L in primary immune thrombocytopenia
. British Journal of Haematology 178:2, pages 308-318.
Crossref
Crossref
Takashi Satoh & Masataka Kuwana. 2017. Autoimmune Thrombocytopenia . Autoimmune Thrombocytopenia
63
72
.
Xin Guo, Dai Li, Min Chen, Lei Chen, Bikui Zhang, Tian Wu & Ren Guo. (2016) miRNA-145 inhibits VSMC proliferation by targeting CD40. Scientific Reports 6:1.
Crossref
Crossref
Sameh Sarray & Wassim Y. Almawi. (2016) Levels of CD40L and other inflammatory biomarkers in obese and non-obese women with polycystic ovary syndrome. American Journal of Reproductive Immunology 76:4, pages 285-291.
Crossref
Crossref
Javad Sanchooli, Nourollah Ramroodi, Nima Sanadgol, Vida Sarabandi, Hadi Ravan & Reza Saebi Rad. (2014) Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis. The Kaohsiung Journal of Medical Sciences 30:5, pages 235-242.
Crossref
Crossref
Bikui Zhang, Tian Wu, Cuizhu Song, Min Chen, Huande Li & Ren Guo. (2013) Association of CD40 −1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population. International Immunopharmacology 16:4, pages 461-465.
Crossref
Crossref
H.O. El-Mesallamy, R.S. Abd El-Razek & T.A. El-Refaie. (2013) Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 168:2, pages 178-182.
Crossref
Crossref
Zhi-Nian Zhong, Shao-Fang Zhu, Ai-Dong Yuan, Guo-Hui Lu, Zheng-Yan He, Zhi-Qiang Fa & Wen-Hu Li. (2012) Potential of Placenta-derived Mesenchymal Stem Cells as Seed Cells for Bone Tissue Engineering: Preliminary Study of Osteoblastic Differentiation and Immunogenicity. Orthopedics 35:9, pages 779-788.
Crossref
Crossref
J. WANG, W. ZHANG, M.A. NARDI & Z. LI. (2011) HIV‐1 Tat‐induced platelet activation and release of CD154 contribute to HIV‐1‐associated autoimmune thrombocytopenia. Journal of Thrombosis and Haemostasis 9:3, pages 562-573.
Crossref
Crossref
Muhammad Rizvi, Didi Pathak, Jane E. Freedman & Subrata Chakrabarti. (2008) CD40–CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends in Molecular Medicine 14:12, pages 530-538.
Crossref
Crossref